Address
Building Two, Parkmore Business Park West
Galway, GA H91 4K49
Ireland
Phone
353 1 438 1700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
95000
First IPO Date
May 02, 1973
| Name | Title | Pay | Year Born |
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer | 4.09M | 1970 |
| Kweli Thompson | Executive Vice President & President of Neuroscience Portfolio | 1.86M | 1968 |
| Brett A. Wall | Executive Officer | 2M | 1966 |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary | 2.49M | 1969 |
| Thierry Pieton | Executive Vice President & Chief Financial Officer | 4.22M | 1970 |
| Dave Moeller | Senior VP & President of the Peripheral Vascular Health Operating Unit | 0 | N/A |
| Austin L. Chiang | Chief Medical Officer Gastrointestinal Business | 0 | N/A |
| Alan Cheng | Chief Medical Officer of Cardiac Rhythm Management | 0 | N/A |
| Robert Adam Hopkins | Senior Vice President & Head of Global Strategy | 0 | 1968 |
| Robert Kowal | VP & GM of Cardiac Pacing Therapies | 0 | N/A |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer | 0 | N/A |
| Ingrid Goldberg | Vice President & Head of Investor Relations | 0 | N/A |
| Linnea Burman | Senior VP and President of Medtronic's Neurovascular business | 0 | N/A |
| Sally Saba | Chief Inclusion & Diversity Officer | 0 | N/A |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing | 0 | 1979 |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer | 0 | 1970 |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer | 0 | N/A |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business | 0 | N/A |
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.